Our main hypothesis regarding CD20+ T-cells was that they may play a more competent role in the tumor elimination compared to CD20- T-cells which is supported by the elevated incidence of CD20+ T-cells in MGUS and MM and the expression of CD8, NKG2D, and CD28. The gene discussed is KLRK1; the disease is Miyoshi myopathy.